There is evidence that even major and/or cancer-initiating driver mutations (e.g. APC, IDH1/2, KRAS, PIK3CA, etc.)are differentially selected depending on cancer type [37], strongly suggesting a role for the TME, broadly defined, in selecting many of the common driver mutations. The gene discussed is KRAS; the disease is cancer.